The Sanguine Journal Press

Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Translational Research Initiatives

anadeem 1 min read September 2023
Our first apheresis donor center- Sanguine Biosciences Inc.

The facility in the heart of Los Angeles enables the delivery of the highest quality and most relevant disease-state and healthy leukopaks to our clients in advanced therapy research and development as part of our commitment to bringing new treatments to patients.

Interested in participating?

Join the Sanguine donor community and get matched to studies that fit your health profile and location.

Sign up Browse conditions
Keep reading
Patients

Scleroderma Treatment: Options and What to Expect

Scleroderma treatment can't cure the disease yet, but it can do a lot: slow the hardening of skin…

6 min read August 2026
Patients

Scleroderma Symptoms: Early Signs to Watch For

Scleroderma symptoms often begin in the hands — fingers that change color in the cold, puffy or swollen…

6 min read August 2026
Patients

Sjögren’s Treatment: Options and What to Expect

Sjögren's treatment can't cure the disease yet, but it can do a great deal: relieve the dry eyes…

7 min read August 2026